Dengue Vaccine Market Analysis, Overview, Drivers and Restraints
- Get link
- X
- Other Apps
Dengue fever, often known as breakbone fever, is a viral virus transmitted by mosquitos that causes a severe flu-like disease. Severe dengue fever is a potentially fatal consequence of the disease. Dengue vaccine is a human vaccine that prevents dengue disease. Dengue fever is an infectious disease spread by mosquitos that affects both animals and humans. It is caused by the dengue virus, which belongs to the Flaviviridae family and genus Flavivirus. It spreads from one person to another through the bite of an infected Aedes Aegypti mosquito. Dengue fever is characterised by a high temperature, exhaustion, headache, diarrhoea, muscle discomfort, skin rashes, anaemia, and vomiting. Seizures, yellow skin, unconsciousness, and even death are among symptoms of dengue fever in its most severe form. It has a high death rate and can lead to significant neurological problems. Dengue fever causes CNS symptoms such as aberrant neurological signals, altered consciousness, delirium, and generalised and localised convulsions.
Global Dengue Vaccine Market: Drivers
Over the forecast period, the
worldwide dengue
vaccine market is expected to rise due to rising dengue prevalence.
According to the Pan American Health Organization, a total of 1,191,815 cases
of dengue fever were recorded in the Americas region between epidemiological
weeks 1 and 22 of 2019, with 546,589 cases being laboratory-confirmed and 5,599
being categorised as severe dengue.
Dengue Vaccine Market |
Furthermore, market expansion is
likely to be aided by R&D of live attenuated vaccines. Dengvaxia, for
example, was licenced by the US Food and Drug Administration in May 2019 for
the prevention of dengue fever caused by all dengue virus serotypes. It's a
chimaera vaccine developed with recombinant DNA that's live attenuated and
tetravalent.
Global Dengue Vaccine Market: Restraints
The market's growth is projected to be
hampered by the inability to distinguish dengue fever from other febrile
disorders. The symptoms of mosquito-borne infections like Zika, chikungunya
virus infection, and dengue fever, for example, are extremely similar, making
diagnosis challenging. Furthermore, the market's expansion is projected to be
hampered by a lack of understanding of the pathophysiology of dengue infection
and a lack of appropriate animal models.
- Get link
- X
- Other Apps
Comments
Post a Comment